Dropless Pars Plana Vitrectomy Study

NCT05331664 · clinicaltrials.gov ↗

PHASE4

Phase

RECRUITING

Status

168

Enrollment

OTHER

Sponsor class

Conditions

Rhegmatogenous Retinal Detachment

Interventions

PROCEDURE: Pars plana vitrectomy
DRUG: Triamcinolone Acetonide 40mg/mL
DRUG: Moxifloxacin 0.5% or Polymyxin/Trimethoprim if patient is allergic to moxifloxacin
DRUG: Prednisolone 1%
DRUG: Atropine 1%

Sponsor

Massachusetts Eye and Ear Infirmary